Pharmaceutical Accountability Foundation (@PharmAccFound) profile picture

the Pharmaceutical Accountability Foundation is the English international account of the Dutch non-profit Stichting Farma ter Verantwoording @StichtingFTV

The Netherlands
Joined February 2019
Pharmaceutical Accountability Foundation retweeted
.@StichtingFTV verwelkomt het advies van het @ZiNLActueel om het door #medicijnkaper @LupinGlobal 100 maal duurder gemaakte #mexiletine (Namuscla®) niet te vergoeden. Persbericht: farmaterverantwoording.nl/en…
3
2
.@StichtingFtV feliciteert zorgverzekeraar @Menzis met een historische overwinning in evergreening zaak over Seroquel (antipsychoticum quietapine). Volgens rechtbank heeft @AstraZeneca onterecht voordeel gehad, en moet zij dit terugbetalen aan MENZIS. farmaterverantwoording.nl/fa…
Orphan drugs making billions for #BigPharma. we need a different system to reward R&D for rare diseases that cannot be misused!
European legislation designed to help patients with rare diseases has yielded lucrative results for the drug industry, finds a new investigation published in @bmj_latest and the Dutch Journal of Medicine ow.ly/YIrg50AKqUz
Dutch pharma lobby tried to undermine and rewrite an official government committee report on Compulsory Licensing
This Post is from a suspended account. Learn more
4
2
.@StichtingFTV is indeed proud that its chair received this Royal Award of Officer in the Order of Orange-Nassau
This Post is from an account that no longer exists. Learn more
1
4
English translation of a press release of the Dutch Competition Authority (Netherlands Authority for Consumers and Markets, @AutoriteitCM) on #CDCA #Leadiant acm.nl/en/publications/acm-e…
De ACM verlengt het onderzoek naar het weesgeneesmiddel CDCA van fabrikant Leadiant: acm.nl/nl/publicaties/acm-ze…
The Dutch Competition Authority ACM @AutoriteitCM announced today that they are continuing the investigation of pharmaceutical company #Leadiant in price setting of orphan drug #CDCA which became 500x more expensive since 2008. @StichtingFTV
De ACM verlengt het onderzoek naar het weesgeneesmiddel CDCA van fabrikant Leadiant: acm.nl/nl/publicaties/acm-ze…
the financialisation of Big Pharma - this cannot be sustainable
New @SOMO research reveals Big Pharma’s business model has shifted radically since 2000, with more investment in financial activities than in R&D for new drugs. This leaves the sector vulnerable in times of crisis, with potentially high costs for society. somo.nu/3egg5wR
If you start with the 11 pence/capsule price in 2005 for heart rythm problems by originator @Boehringer, the price increase is 420x as #LUPIN asks 50 pounds/capsule in 2018 for the orphan disease Non-dystrophic Myotonia. Uncceptable! @StichtingFTV
Lupin has increased the price of mexiletine from €450 to €85000/patient/year. Cardiology patients now need off-label prescriptions of an excessively priced orphan drug! Continued misuse of orphan drug legislation: a life-threatening risk for mexiletine. doi.org/10.1093/eurheartj/eh…
Lupin has increased the price of mexiletine from €450 to €85000/patient/year. Cardiology patients now need off-label prescriptions of an excessively priced orphan drug! Continued misuse of orphan drug legislation: a life-threatening risk for mexiletine. doi.org/10.1093/eurheartj/eh…
inderdaad een gemiste kans, dit doekje voor het bloeden. Hoe kan een farma gedragscode niet praten over (redelijke) prijzen? Zorgplicht? @Wemos @ellenthoen @StichtingFTV
This quoted post is unavailable.
1
#Leadiant now also investigated by Italian Competition Authority after earlier complaints in Netherlands, Belgium and Spain about misuse economic power and 500x price increase of #CDCA for #CTX @StichtingFTV @AutoriteitCM @Testaankoop @Altroconsumo agcm.it/media/dettaglio?id=5…
Een jaar geleden diende @StichtingFTV een klacht over #CDCA in bij @AutoriteitCM. Sindsdien hebben in Belgie, Italie en ook Spanje organisaties Leadiant aangeklaagd bij mededingings autoriteiten. ocu.org/organizacion/prensa/…
4
2